Charlotte’s health innovation scene is getting another test run, this time with a sharper focus on community health.

Five local startups have been selected for the fall 2026 cohort of gBETA Charlotte Health, a seven-week accelerator run by gener8tor in partnership with the City of Charlotte and Advocate Health.

The program is free, takes no equity and is based at The Pearl, Advocate Health’s growing innovation district near Uptown.

More than 50 companies applied for the cohort, and the five selected startups are working on very different problems: mobile medical care, healthy aging, medication access, chronic pain and heart diagnostics.

What connects them is the idea that health innovation should solve problems people actually feel in daily life.

The cohort was built around six community-health priorities identified for Charlotte: access to care, behavioral health, chronic disease, maternal and infant health, social drivers of health, and community safety.

That makes this group more than a collection of promising startups.

It is also a snapshot of the kinds of health gaps Charlotte’s innovation ecosystem is trying to address.

Carviq wants to make mobile medicine easier to run

Carviq is building an AI-native operational platform for house-call and mobile medical practices.

The company’s tools are designed to help providers handle scheduling, care delivery and field operations outside traditional clinics.

That matters because bringing healthcare into homes and neighborhoods can improve convenience for patients, but it also creates operational challenges for providers.

If the model works, Carviq could help make mobile care more efficient and easier to scale.

ForesightCares is focused on healthy aging

ForesightCares is developing AI-powered mobility assessment and remote-monitoring tools for older adults.

The technology is intended to help providers monitor movement, identify risk and support more preventive care, particularly in rural and underserved communities.

That puts the company at the intersection of aging, access and prevention.

For older adults, catching a mobility problem early can mean the difference between staying independent and facing a much larger health event later.

Global Bridge Pharmaceutical is tackling medication access

Global Bridge Pharmaceutical is creating a marketplace platform that connects organizations with medication sourcing, financial-assistance programs and surplus pharmaceutical inventory.

The concept aims to solve two problems at once: wasted medication resources and patients struggling to get the drugs they need.

Healthcare organizations could use the platform to manage drug resources more efficiently, while patients may benefit from better access to assistance programs and available inventory.

Rethink Health is starting with knee osteoarthritis

Rethink Health is developing research-based programs that help people understand pain and manage musculoskeletal conditions more effectively.

Its first program focuses on knee osteoarthritis and encourages people to build confidence in movement and use conservative self-management strategies.

That approach could matter for people who are living with chronic pain but may not immediately need surgery or more intensive treatment.

It also reflects a broader shift in healthcare toward helping patients manage conditions earlier and more proactively.

SonoVivo is working on noninvasive heart diagnostics

SonoVivo is developing ultrasound-based diagnostic equipment that measures cardiac pressure without an invasive procedure.

The company says its technology could help relieve pressure on catheterization labs, expand access to screening and reduce the need for specialists in underserved areas.

If the technology proves effective, it could make certain heart assessments easier to deliver outside major medical centers.

Why Charlotte is investing in this

The program is as much about Charlotte’s economic strategy as it is about health.

The city has been using gBETA to help early-stage companies build relationships, sharpen their business models and become more investor-ready.

Since gBETA Charlotte launched in 2024, the program has supported 15 companies that have collectively raised $2.6 million and created 82 jobs.

This is the fourth overall Charlotte cohort and the second specifically focused on health innovation in partnership with Advocate Health.

The broader bet is that Charlotte can become known not only for banking and fintech, but also for healthcare innovation.

The Pearl plays a central role in that ambition.

During the seven-week program, founders will spend much of their time at Connect Labs Charlotte, where they can work near healthcare institutions, researchers, mentors, investors and other startups.

That concentration of people and resources is designed to shorten the distance between an idea and a real-world pilot.

What happens next

The cohort began in mid-October and will culminate in a public showcase on December 9 at The Pearl.

That event will give the startups a chance to present their progress to investors, mentors and the broader community.

For Charlotte residents, the more important question is what happens after the pitches.

Will any of these companies improve access to care, make treatment easier to navigate or create solutions that reach people who are currently underserved?

Those outcomes will take longer to measure.

For now, the fall cohort shows where Charlotte’s health-innovation priorities are moving: closer to the everyday problems of aging, access, medication, chronic disease and diagnosis.

Sources & further reading

City of Charlotte: Five Companies Selected for Charlotte’s Health Innovation Accelerator

gener8tor: gBETA Charlotte Health program overview

The Pearl: Charlotte health innovation district overview